ARCHIVES

Risk-Benefit Analysis Advised Prior To Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Fred Conrad, MDA VP, Shot To Death In Hospital Office

January 7, 1983

ASCO Urges Sustained Support For Cancer Research, Clinical Trials

March 27, 2009

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013

Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers

April 29, 1994

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

Robert Day Named New Director At Hutchinson Center

June 19, 1981